Comparing Profusa (PFSA) and Its Rivals

Profusa (NASDAQ:PFSA) is one of 27 public companies in the “Surgical, Medical, And Dental Instruments And Supplies” industry, but how does it contrast to its peers? We will compare Profusa to similar companies based on the strength of its earnings, profitability, analyst recommendations, risk, dividends, valuation and institutional ownership.

Earnings & Valuation

This table compares Profusa and its peers top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Profusa	N/A	-$8.71 million	-1.36
Profusa Competitors	$63.73 million	-$35.30 million	3.92

Profusa’s peers have higher revenue, but lower earnings than Profusa. Profusa is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider and Institutional Ownership

9.8% of Profusa shares are held by institutional investors. Comparatively, 22.5% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by institutional investors. 11.4% of Profusa shares are held by company insiders. Comparatively, 18.4% of shares of all “Surgical, Medical, And Dental Instruments And Supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Volatility & Risk

Profusa has a beta of -0.14, meaning that its share price is 114% less volatile than the S&P 500. Comparatively, Profusa’s peers have a beta of 1.46, meaning that their average share price is 46% more volatile than the S&P 500.

Profitability

This table compares Profusa and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Profusa	N/A	N/A	-880.32%
Profusa Competitors	-672.41%	-133.75%	-59.01%

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Profusa and its peers, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Profusa	1	0	0	0	1.00
Profusa Competitors	75	75	156	6	2.30

As a group, “Surgical, Medical, And Dental Instruments And Supplies” companies have a potential upside of 50.63%. Given Profusa’s peers stronger consensus rating and higher possible upside, analysts plainly believe Profusa has less favorable growth aspects than its peers.

Summary

Profusa peers beat Profusa on 10 of the 13 factors compared.

Profusa Company Profile

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.